These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37854773)

  • 1. Corrigendum to "Function of N6-Methyladenosine Modification in Tumors".
    Zhang N; Zuo Y; Peng Y; Zuo L
    J Oncol; 2023; 2023():9870174. PubMed ID: 37854773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum: Distribution Patterns of DNA N6-Methyladenosine Modification in Non-coding RNA Genes.
    Li Y; Zhang XM; Luan MW; Xing JF; Chen J; Xie SQ
    Front Genet; 2020; 11():904. PubMed ID: 33061934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
    Front Med (Lausanne); 2023; 10():1251795. PubMed ID: 37497273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Roles of N6-Methyladenosine (m
    Zhang M; Zhai Y; Zhang S; Dai X; Li Z
    Front Cell Dev Biol; 2021; 9():640806. PubMed ID: 33553192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers.
    Tan S; Li Z; Li K; Li Y; Liang G; Tang Z; Kang J; Chen W; Li M; Zou Z; Pi G; Zhu X
    Front Cell Dev Biol; 2022; 10():843275. PubMed ID: 35356280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Mettl14-mediated m6A modification enhances the function of Foxp3
    Liu Y; Yuan Y; Zhou Z; Cui Y; Teng Y; Huang H; Yuan H; Zhang Y; Yang L; Zhao G
    Front Immunol; 2022; 13():1112027. PubMed ID: 36605201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer.
    Liu J; Wang J; Wu M; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
    Front Med (Lausanne); 2021; 8():757432. PubMed ID: 35004726
    [No Abstract]   [Full Text] [Related]  

  • 8. One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia.
    Ouyang X; Gong Y
    Front Immunol; 2022; 13():912526. PubMed ID: 35720276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Relevance of RNA N6-methyladenosine regulators for pulmonary fibrosis: Implications for chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis.
    Zhou Y; Fang C; Sun Q; Dong Y
    Front Genet; 2022; 13():1056103. PubMed ID: 36330436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.
    Chen K; Zhu S; Yu W; Xia Y; Xing J; Geng J; Cheng F
    Front Oncol; 2022; 12():908832. PubMed ID: 35600386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Identifying key m
    Yang J; Xu J; Zhang L; Li Y; Chen M
    Front Genet; 2023; 14():1198975. PubMed ID: 37496715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma.
    Zhang Y; Geng X; Xu J; Li Q; Hao L; Zeng Z; Xiao M; Song J; Liu F; Fang C; Wang H
    J Cell Mol Med; 2021 Aug; 25(15):7204-7217. PubMed ID: 34180136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA N6-methyladenosine (m6A) modification in HNSCC: molecular mechanism and therapeutic potential.
    Sun X; Fu S; Yuan X; Pu X; Wang R; Wang X; Lu H
    Cancer Gene Ther; 2023 Sep; 30(9):1209-1214. PubMed ID: 37221404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Roles of RNA N6-Methyladenosine in Urological Tumors.
    Li Y; Ge YZ; Xu L; Xu Z; Dou Q; Jia R
    Front Cell Dev Biol; 2020; 8():579919. PubMed ID: 33015074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell-mediated antitumor activity.
    Zheng H; Zheng WJ; Wang ZG; Tao YP; Huang ZP; Yang L; Ouyang L; Duan ZQ; Zhang YN; Chen BN; Xiang DM; Jin G; Fang L; Zhou F; Liang B
    Front Immunol; 2022; 13():1093403. PubMed ID: 36591292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA methylation in vascular disease: a systematic review.
    Shu Y; Guo Y; Zheng Y; He S; Shi Z
    J Cardiothorac Surg; 2022 Dec; 17(1):323. PubMed ID: 36536469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA
    Li Y; Wang J; Huang C; Shen M; Zhan H; Xu K
    Cell Biosci; 2020; 10():19. PubMed ID: 32110378
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of RNA N6-Methyladenosine Modification in Male Infertility and Genital System Tumors.
    Liu S; Lao Y; Wang Y; Li R; Fang X; Wang Y; Gao X; Dong Z
    Front Cell Dev Biol; 2021; 9():676364. PubMed ID: 34124065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic deamination of the epigenetic nucleoside N6-methyladenosine regulates gene expression.
    Jiang Z; Wang C; Wu Z; Chen K; Yang W; Deng H; Song H; Zhou X
    Nucleic Acids Res; 2021 Dec; 49(21):12048-12068. PubMed ID: 34850126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of N6-methyladenosine modification in tumor immunity and immunotherapy.
    Zhang Z; Liu F; Chen W; Liao Z; Zhang W; Zhang B; Liang H; Chu L; Zhang Z
    Exp Hematol Oncol; 2022 May; 11(1):30. PubMed ID: 35590394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.